Page 58 - Read Online

Kamal et al. J Transl Genet Genom 2024;8:162-85 https://dx.doi.org/10.20517/jtgg.2023.55 Page 182

2011;3:20. DOI PubMed PMC
65. Riva P, Ratti A, Venturin M. The long non-coding RNAs in neurodegenerative diseases: novel mechanisms of pathogenesis. Curr
Alzheimer Res 2016;13:1219-31. DOI
66. Airavaara M, Pletnikova O, Doyle ME, Zhang YE, Troncoso JC, Liu QR. Identification of novel GDNF isoforms and cis-antisense
GDNFOS gene and their regulation in human middle temporal gyrus of Alzheimer disease. J Biol Chem 2011;286:45093-102. DOI
PubMed PMC
67. Massone S, Vassallo I, Fiorino G, et al. 17A, a novel non-coding RNA, regulates GABA B alternative splicing and signaling in
response to inflammatory stimuli and in Alzheimer disease. Neurobiol Dis 2011;41:308-17. DOI
68. Parenti R, Paratore S, Torrisi A, Cavallaro S. A natural antisense transcript against Rad18, specifically expressed in neurons and
upregulated during beta-amyloid-induced apoptosis. Eur J Neurosci 2007;26:2444-57. DOI
69. Mus E, Hof PR, Tiedge H. Dendritic BC200 RNA in aging and in Alzheimer's disease. Proc Natl Acad Sci USA 2007;104:10679-84.
DOI PubMed PMC
70. Ciarlo E, Massone S, Penna I, et al. An intronic ncRNA-dependent regulation of SORL1 expression affecting Aβ formation is
upregulated in post-mortem Alzheimer's disease brain samples. Dis Model Mech 2013;6:424-33. DOI PubMed PMC
71. Massone S, Ciarlo E, Vella S, et al. NDM29, a RNA polymerase III-dependent non coding RNA, promotes amyloidogenic processing
of APP and amyloid β secretion. Biochim Biophys Acta 2012;1823:1170-7. DOI
72. Gu C, Chen C, Wu R, et al. Long noncoding RNA EBF3-AS promotes neuron apoptosis in Alzheimer's disease. DNA Cell Biol
2018;37:220-6. DOI
73. Ferreira JJ, Rodrigues FB, Duarte GS, et al. An MDS evidence-based review on treatments for Huntington's disease. Mov Disord
2022;37:25-35. DOI
74. Lee M, Liu T, Im W, Kim M. Exosomes from adipose-derived stem cells ameliorate phenotype of Huntington's disease in vitro
model. Eur J Neurosci 2016;44:2114-9. DOI PubMed
75. McColgan P, Tabrizi SJ. Huntington's disease: a clinical review. Eur J Neurol 2018;25:24-34. DOI PubMed
76. Chung DW, Rudnicki DD, Yu L, Margolis RL. A natural antisense transcript at the Huntington's disease repeat locus regulates HTT
expression. Hum Mol Genet 2011;20:3467-77. DOI PubMed PMC
77. Sunwoo JS, Lee ST, Im W, et al. Altered expression of the long noncoding RNA NEAT1 in Huntington's disease. Mol Neurobiol
2017;54:1577-86. DOI
78. Koistinen H, Kovanen RM, Hollenberg MD, et al. The roles of proteases in prostate cancer. IUBMB Life 2023;75:493-513. DOI
PubMed PMC
79. Chakravarty D, Sboner A, Nair SS, et al. The oestrogen receptor alpha-regulated lncRNA NEAT1 is a critical modulator of prostate
cancer. Nat Commun 2014;5:5383. DOI
80. Yuan S, Bi J, Zhang Y. LncRNA SSTR5-AS1 as a prognostic marker promotes cell proliferation and epithelial-to-mesenchymal
transition in prostate cancer. Crit Rev Eukaryot Gene Expr 2023;33:1-12. DOI PubMed
81. Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2022. CA Cancer J Clin 2022;72:7-33. DOI PubMed
82. Sideris N, Dama P, Bayraktar S, Stiff T, Castellano L. LncRNAs in breast cancer: a link to future approaches. Cancer Gene Ther
2022;29:1866-77. DOI PubMed PMC
83. Sang Y, Tang J, Li S, et al. LncRNA PANDAR regulates the G1/S transition of breast cancer cells by suppressing p16(INK4A)
expression. Sci Rep 2016;6:22366. DOI PubMed PMC
84. Zhang J, Sui S, Wu H, et al. The transcriptional landscape of lncRNAs reveals the oncogenic function of LINC00511 in ER-negative
breast cancer. Cell Death Dis 2019;10:599. DOI PubMed PMC
85. Li H, Chen C, Fan J, et al. Identification of cardiac long non-coding RNA profile in human dilated cardiomyopathy. Cardiovasc Res
2018;114:747-58. DOI
86. Zhang X, Yuan S, Liu J, et al. Overexpression of cytosolic long noncoding RNA cytb protects against pressure-overload-induced
heart failure via sponging microRNA-103-3p. Mol Ther Nucleic Acids 2022;27:1127-45. DOI PubMed PMC
87. Xie R, Fan J, Wen J, et al. LncRNA ZNF593-AS alleviates diabetic cardiomyopathy via suppressing IRF3 signaling pathway. Mol
Ther Nucleic Acids 2023;32:689-703. DOI PubMed PMC
88. Fan J, Li H, Xie R, et al. LncRNA ZNF593-AS alleviates contractile dysfunction in dilated cardiomyopathy. Circ Res
2021;128:1708-23. DOI
89. Zhong J, Jiang L, Huang Z, et al. The long non-coding RNA Neat1 is an important mediator of the therapeutic effect of bexarotene on
traumatic brain injury in mice. Brain Behav Immun 2017;65:183-94. DOI
90. Patel NA, Moss LD, Lee JY, et al. Long noncoding RNA MALAT1 in exosomes drives regenerative function and modulates
inflammation-linked networks following traumatic brain injury. J Neuroinflamm 2018;15:204. DOI PubMed PMC
91. Harris L, Zalucki O, Piper M, Heng JI. Insights into the biology and therapeutic applications of neural stem cells. Stem Cells Int
2016;2016:9745315. DOI PubMed PMC
92. Zheng J, Yi D, Liu Y, Wang M, Zhu Y, Shi H. Long nonding RNA UCA1 regulates neural stem cell differentiation by controlling
miR-1/Hes1 expression. Am J Transl Res 2017;9:3696-704. Available from: https://europepmc.org/article/MED/28861160 [Last
accessed on 1 Apr 2024].
93. Liu Y, Pan L, Jiang A, Yin M. Hydrogen sulfide upregulated lncRNA CasC7 to reduce neuronal cell apoptosis in spinal cord
ischemia-reperfusion injury rat. Biomed Pharmacother 2018;98:856-62. DOI